Original paper
Epidemiological estimates and early detection of polycystic kidney disease by ultrasonographic assessment in Japan., Kobayashi Minoru;Kamai Takao, Medical ultrasonography, 25 May 2022
Clinical Significance of 18F-fluorodeoxyglucose and Glucose Transporter 1 mRNA in Clear Cell Renal Cell Carcinoma., Betsunoh Hironori;Sakamoto Setsu;Kaji Yasushi;Nukui Akinori;Kobayashi Minoru;Yashi Masahiro;Hayashi Keitaro;Anzai Naohiko;Kamai Takao, Anticancer research, 41(10), 5179-5188, Oct. 2021
Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma., Kamai Takao;Higashi Satoru;Murakami Satoshi;Arai Kyoko;Namatame Takashi;Kijima Toshiki;Abe Hideyuki;Jamiyan Tsengelmaa;Ishida Kazuyuki;Shirataki Hiromichi;Yoshida Ken-Ichiro, Cancer science, 112(8), 3375-3387, Aug. 2021
Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma., Mizuno Tomoya;Kamai Takao;Tsuzuki Toyonori;Nishihara Daisaku;Kijima Toshiki;Arai Kyoko;Yoshida Ken-Ichiro, Cancer immunology, immunotherapy : CII, 18 Jul. 2021
Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival., Kamai Takao;Kijima Toshiki;Tsuzuki Toyonori;Nukui Akinori;Abe Hideyuki;Arai Kyoko;Yoshida Ken-Ichiro, Cancer immunology, immunotherapy : CII, 70(7), 2009-2021, Jul. 2021
Comparative accuracy of the Lilium α-200 portable ultrasound bladder scanner and conventional transabdominal ultrasonography for postvoid residual urine volume measurement in association with the clinical factors involved in measurement errors., Yamaguchi Yoshiyuki;Kamai Takao;Kobayashi Minoru, Neurourology and urodynamics, 40(1), 183-192, Jan. 2021
Genetic alteration of ARMC5 in a patient diagnosed with meningioma and primary macronodular adrenal hyperplasia: a case report., Jojima Teruo;Kogai Takahiko;Iijima Toshie;Kato Kanako;Sagara Masaaki;Kezuka Atsumi;Kase Masato;Sakurai Shintaro;Akimoto Kazumi;Sakumoto Junko;Namatame Takashi;Ueki Keisuke;Hishinuma Akira;Kamai Takao;Usui Isao;Aso Yoshimasa, European journal of endocrinology, 183(6), K7-K12, Dec. 2020
Plasmacytoid urothelial carcinoma of renal pelvis with positive zinc finger E-box-binding homeobox 1: a case report., Takada-Owada Atsuko;Nozawa Yumi;Onozaki Masato;Noda Shuhei;Jamiyan Tsengelmaa;Tokura Yuumi;Nakazato Yoshimasa;Kamai Takao;Ishida Kazuyuki, Diagnostic pathology, 15(1), 124, 08 Oct. 2020
Detection of Muscle-Invasive Bladder Cancer on Biparametric MRI Using Vesical Imaging-Reporting and Data System and Apparent Diffusion Coefficient Values(VI-RADS/ADC), Sakamoto k, Ito M, Ikutab S, Nakanishia Y, Kataoka M, Takemura K, Suzuki H, Tobisu K-I, Kamai T, Koga F, Bladder Cancer, 6, 161-169, Jun. 2020
Association of cancer progression with elevated expression of programmed cell death protein 1 ligand 1 by upper tract urothelial carcinoma and increased tumor-infiltrating lymphocyte density, Nukui A, Kamai T, Arai K, Kijima T, Kobayashi M, Narimatsu T, Kambara T, Yuki H, Betsunoh H, Abe H, Fukabori Y, Yashi M, Yoshida KI, Cancer Immunol Immunother, 1(1), 1-702, May 2020
Association between serum prostate-specific antigen level and diabetes, obesity, hypertension, and the laboratory parameters related to glucose tolerance, hepatic function, and lipid profile: implications for modification of prostate-specific antigen threshold, Kobayashi M, Mizuno T,Yuki H,Kambara T,Betsunoh H,Nukui A,Abe H,Fukabori Y,Yashi M,Kamai T, Int J Clin Oncol, 1(1), 1-478, Mar. 2020
Sex steroid hormone receptors in bladder cancer: Usefulness in differential diagnosis and implications in histogenesis of bladder cancer, Imai Y, Noda S, Matsuyama C, Shimizu A, Kamai T, Urol Oncol, 37(6), 353000000000-353000000000000000, Jun. 2019
Feeling of incomplete emptying with little post-void residual in patients with lower urinary tract symptoms: Clinical implications and treatment outcomes, Kobayashi M, Tokura Y,Kambara T,Nukui A,Kamai T, Low Urin Tract Symptoms, 1(2), 1-O64, Apr. 2019
Immunohistochemical expressionof sodium-dependent glucose transporter - 2 (SGLT-2) in clear cell renal carcinoma: possible prognostic implications, Kobayashi M, Uematsu T, Tokura Y, Takei K, Sakamoto K, Narimatsu T, Nukui A, Kamai T, Int Braz J Urol, 44(1), 1-178, Jan. 2019
Carbon dioxide insufflation to control intractable bleeding during transurethral resection of bladder tumor, Kobayashi M, Kamai T, Indian J Urol, 35(1), 73-74, Jan. 2019
The Predictive Value of Glycated Hemoglobin and Albumin for the Clinical Course Following Hospitalization of Patients with Febrile Urinary Tract Infection, Kobayashi M, Uematsu TNakamura GKokubun HMizuno TBetsunoh HKamai T, Infect Chemother, 50(3), 228-237, Sep. 2018
Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis, Yuki H, Kamai T, Murakami S, Higashi S, Narimatsu T, Kambara T, Betsunoh H, Abe H, Arai K, Shirataki H, Yoshida KI, Oncotarget, 9(47), 28351-28363, Jun. 2018
Clinically significant association of elevated expression of nuclear factor E2-related factor 2 expression with higher glucose uptake and progression of upper urinary tract cancer, Nukui A, Narimatsu TKambara TAbe HSakamoto SYoshida KIKamai T, BMC Cancer, 18(1), 493, May 2018
Comparative Efficacy and Tolerability of Antimuscarinic Agents and the Selective beta3-Adrenoceptor Agonist, Mirabegron, for the Treatment of Overactive Bladder: Which is More Preferable as an Initial Treatment?, Kobayashi M, Nukui AKamai T, Low Urin Tract Symptoms, 10(2), 158-166, May 2018
Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy, Abe H, Takei KUematsu TTokura YSuzuki ISakamoto KNishihara DYamaguchi YMizuno TNukui AKobayashi MKamai T, Int J Clin Oncol, 23(2), 338-346, Apr. 2018
A case of giant hemorrhagic hydrocele testis, Tokura Y, Kobayashi MKamai T, Urol Case Rep, 18, 44-45, Mar. 2018
Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma, Nukui A, Yanai YTsuzuki TAbe HArai KYoshida KIKamai T, Oncotarget, 9(3), 4188-4199, Jan. 2018
Elevated serum levels of cardiovascular biomarkers are associated with progression of renal cancer, Kamai T, Tokura YUematsu TSakamoto KSuzuki ITakei KNarimatsu TKambara TYuki HBetsunoh HAbe HFukabori YYashi MYoshida KI, Open Heart, 5(1), e000666, Jan. 2018
Seasonal Changes in Lower Urinary Tract Symptoms in Japanese Men With Benign Prostatic Hyperplasia Treated With alpha1-Blockers, Kobayashi M, Nukui AKamai T, Int Neurourol J, 21(3), 197-203, Sep. 2017
Performance characteristics of prostate-specific antigen density and biopsy core details to predict oncological outcome in patients with intermediate to high-risk prostate cancer underwent robot-assisted radical prostatectomy, Yashi M, Nukui ATokura YTakei KSuzuki ISakamoto KYuki HKambara TBetsunoh HAbe HFukabori YNakazato YKaji YKamai T, BMC Urol, 17(1), 47, Jun. 2017
Increased serum level of soluble interleukin-2 receptor is associated with a worse response of metastatic clear cell renal cell carcinoma to interferon alpha and sequential VEGF-targeting therapy, Nukui A, Masuda AAbe HArai KYoshida KIKamai T, BMC Cancer, 17(1), 372, May 2017
Psychological impact of serial prostate-specific antigen tests in Japanese men waiting for prostate biopsy, Kobayashi M, Nukui AKamai T, Int J Clin Oncol, 22(1), 174-180, Feb. 2017
Extravasation of Urine Associated with Bilateral Complete Ureteral Duplication, Vesicoureteral Reflux and Benign Prostatic Hyperplasia, Suzuki I, Kaga KTakei KTokura YSakamoto KNishihara DMizuno TYuki HBetsunoh HAbe HYashi MFukabori YYamanishi TKamai T, Urol Case Rep, 11, 47-49, Feb. 2017
Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma, Fukuda T, Kamai TMasuda ANukui AAbe HArai KYoshida KI, Cancer Med, 1(8), 1-1820, Jun. 2016
Update on advances in molecular PET in urological oncology, Kitajima K, Yamamoto SFukushima KMinamimoto RKamai TJadvar H, Jpn J Radiol, 34(7), 470-485, May 2016
Prognosis of metastatic renal cell carcinoma with first-line Interferon-alpha therapy in the era of molecular-targeted therapy, Kawano Y, Takahashi WEto MKamba TMiyake HFujisawa MKamai TUemura HTsukamoto TAzuma HMatsubara ANishimura KNakamura TOgawa ONaito S, Cancer Sci, 107(7), 1013-1017, Apr. 2016
Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report, Kamai T, Abe HArai KMurakami SSakamoto SKaji YYoshida K, BMC Cancer, 16(1), 232, Mar. 2016
24(1), 61-63, Mar. 2016
Abnormal 18F-FDG uptakes in the prostate due to two different conditions of urine reflux: a mimicker of prostate cancer, Inamura K, Kaji YSakamoto SMasuda AKamai T, Springerplus, 5, 46, Jan. 2016
69(13), 1171-1175, Dec. 2015
28(9), 1577-1583, Sep. 2015
The role of muscarinic receptor subtypes on carbachol-induced contraction of normal human detrusor and overactive detrusor associated with benign prostatic hyperplasia, Yamanishi T, Kaga KFuse MShibata CKamai TUchiyama T, J Pharmacol Sci, 128(2), 65-70, Jun. 2015
Maintenance monotherapy with gemcitabine after standard platinum-based chemotherapy in patients with advanced urothelial cancer, Muto S, Abe HNoguchi TSugiura SKitamura KIsotani SIde HYamaguchi RKamai THorie S, Int J Urol, 22(5), 490-494, May 2015
Information of prostate biopsy positive core: does it affect MR detection of prostate cancer on using 3T-MRI?, Yoshida R, Kaji YTamaki YKatsube TKitagaki HKanbara TKamai T, Jpn J Radiol, 33(5), 246-52, May 2015
42(1), 21-29, Mar. 2015
Clinically significant association between the maximum standardized uptake value on 18F-FDG PET and expression of phosphorylated Akt and S6 kinase for prediction of the biological characteristics of renal cell cancer, Mizuno T, Kamai TAbe HSakamoto SKitajima KNishihara DYuki HKambara TBetsunoh HYashi MFukabori YKaji YYoshida K, BMC Cancer, 15, 1097, Mar. 2015
24(1), 61-63, Mar. 2015
Evidenced-based clinical practice guideline for upper tract urothelial carcinoma (summary--Japanese Urological Association, 2014 edition), Oya M, Kikuchi E, Int J Urol, 22(1), 3-13, Jan. 2015
Metronomic oral cyclophosphamide chemotherapy possibly contributes to stabilization of disease in patients with metastatic castration-resistant prostate cancer: a prospective analysis of consecutive cases, Yashi M, Nishihara DMizuno TYuki HMasuda AKambara TBetsunoh HAbe HFukabori YMuraishi OKamai T, Clin Genitourin Cancer, 12(5), e197-e203, Oct. 2014
27(8), 1271-1273, Aug. 2014
The Rho-kinase inhibitor HA-1077 suppresses proliferation/migration and induces apoptosis of urothelial cancer cells, Abe H, Kamai THayashi KAnzai NShirataki HMizuno TYamaguchi YMasuda AYuki HBetsunoh HYashi MFukabori YYoshida K, BMC Cancer, 14, 412, Jun. 2014
Clinical significance of serum soluble T cell regulatory molecules in clear cell renal cell carcinoma, Masuda A, Arai KNishihara DMizuno TYuki HKambara TBetsunoh HAbe HYashi MFukabori YYoshida KKamai T, Biomed Res Int, 2014, 396064, Jun. 2014
Prostate volume and biopsy tumor length are significant predictors for classical and redefined insignificant cancer on prostatectomy specimens in Japanese men with favorable pathologic features on biopsy, Yashi M, Mizuno TYuki HMasuda AKambara TBetsunoh HAbe HFukabori YMuraishi OSuzuki KNakazato YKamai T, BMC Urol, 14, 43, May 2014
Multicenter, randomized, sham-controlled study on the efficacy of magnetic stimulation for women with urgency urinary incontinence, Yamanishi T, Homma Y, Nishizawa O, Yasuda K, Yokoyama O; SMN-X Study Group, Int J Urol., 21(4), 395-400, Apr. 2014
Nocturia Quality-of-Life questionnaire is a useful tool to predict nocturia and a risk of falling in Japanese outpatients: a cross-sectional survey, Yamanishi T, Fuse MYamaguchi CUchiyama TKamai TKurokawa SMorita T, Int J Urol, 21(3), 289-293, Mar. 2014
LAT1 is a central transporter of essential amino acids in human umbilical vein endothelial cells, Hayashi K, Jutabha PKamai TEndou HAnzai N, J Pharmacol Sci, 124(4), 511-513, Mar. 2014
41(1), 7-12, Mar. 2014
Axitinib for preoperative downstaging of renal cell carcinoma with sarcomatoid differentiation and direct invasion of the duodenum and inferior vena cava: a case report, Yuki H, Kamai TKubota KAbe HNishihara DMizuno TMasuda ABetsunoh HYashi MFukabori YYoshida K, Onco Targets Ther, 7, 289-295, Feb. 2014
Recent advances in the treatment of metastatic renal cell carcinoma, Abe H, Kamai T, Int J Urol, 20(10), 944-955, Oct. 2013
Increased expression of system large amino acid transporter (LAT)-1 mRNA is associated with invasive potential and unfavorable prognosis of human clear cell renal cell carcinoma, Betsunoh H, Fukuda TAnzai NNishihara DMizuno TYuki HMasuda AYamaguchi YAbe HYashi MFukabori YYoshida KKamai T, BMC Cancer, 13, 509, Oct. 2013
24(1), 148-152, Jun. 2013
STAT3 polymorphism can predict the response to interferon-alpha therapy in patients with metastatic renal cell carcinoma, Eto M, Kamba TMiyake HFujisawa MKamai TUemura HTsukamoto TAzuma HMatsubara ANishimura KNakamura TOgawa ONaito S, Eur Urol, 63(4), 745-752, Apr. 2013
Randomized, single-blind, parallel study of the effectiveness and safety of solifenacin versus propiverine in the treatment of overactive bladder, Fukuda T, Yamanishi T, Uchiyama T, Kamai T, LUTS, 201, 11-16, Jan. 2013
Protein profiling of blood samples from patients with hereditary leiomyomatosis and renal cell cancer by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry, Kamai T, Tomosugi NAbe HKaji YOyama TYoshida K, Int J Mol Sci, 13(11), 14518-14532, Nov. 2012
A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma, Shinohara N, Nonomura KAbe TMaruyama SKamai TTakahashi MTatsugami KYokoi SDeguchi TKanayama HOba KNaito S, Cancer Sci, 103(9), 1695-1700, Sep. 2012
25, 693-698, Apr. 2012
Oncocytic carcinoid of the kidney positively detected by I-131 MIBG scintigraphy., Tamaki Y, Hashimoto T, Kamai T, Honma K, Ejima Y, Yamazaki E, Yoshida R, Arakawa H, Kuwashima S, Kaji Y, Sasaki R, Sugimura K, Clin Nucl Med, 36(11), 1025-1028, Nov. 2011
Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinoma, Furuya N, Kamai TShirataki HYanai YFukuda TMizuno TNakamura FKambara TNakanishi KAbe HYoshida K, Cancer Immunol Immunother, 60(6), 793-808, Jun. 2011
Increased alpha-taxilin protein expression is associated with the metastatic and invasive potential of renal cell cancer, Mashidori T, Shirataki HKamai TNakamura FYoshida K, Biomed Res, 32(2), 103-110, Apr. 2011
38(1), 115-118, Mar. 2011
38(1), 17-23, Mar. 2011
1, 171-184, 2011
Urodynamic effects of silodosin, a new alpha 1A-adrenoceptor selective antagonist, for the treatment of benign prostatic hyperplasia, Yamanishi T, Mizuno TTatsumiya KWatanabe MKamai TYoshida K, Neurourol Urodyn, 29(4), 558-562, Apr. 2010
Single minimum incision endoscopic radical nephrectomy for renal tumors with preoperative virtual navigation using 3D-CT volume-rendering, Kamai T, Furuya NKambara TAbe HHonda MShioyama YKaji YYoshida K, BMC Urol, 10, 7, Apr. 2010
Effects of fasudil, a Rho-kinase inhibitor, on contraction of pig bladder tissues with or without urothelium, Tatsumiya K, Yamanishi TWatanabe MMasuda AMizuno TKamai TYoshida K, Int J Urol, 16(12), 959-966, Dec. 2009
Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma, Kamai T, Tomosugi NAbe HArai KYoshida K, BMC Cancer, 9, 270, Aug. 2009
Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?, Masuda A, Kamai TAbe HArai KYoshida K, Biomed Res, 30(3), 171-176, Jun. 2009
Expression of RhoA mRNA and activated RhoA in urothelium and smooth muscle, and effects of a Rho-kinase inhibitor on contraction of the porcine urinary bladder, Nakanishi K, Kamai TMizuno TArai KYamanishi T, Neurourol Urodyn, 28(6), 521-528, Feb. 2009
Possible role of the RhoC/ROCK pathway in progression of clear cell renal cell carcinoma, Abe H, Kamai TTsujii TNakamura FMashidori TMizuno TTanaka MTatsumiya KFuruya NMasuda AYamanishi TYoshida K, Biomed Res, 29(3), 155-161, Jun. 2008
High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma, Abe H, Kamai TShirataki HOyama TArai KYoshida K, Int J Cancer, 122(10), 2391-2397, May 2008
Significant association of interleukin 10 receptor mRNA levels with renal cell carcinoma metastasis, Abe H, Yamanishi TMashidori TArai KKamai T, Biomed Res, 29(1), 19-25, Feb. 2008
Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis, Kamai T, Yanai YArai KAbe HYamanishi TKurimoto MYoshida K, BMC Cancer, 7, 159, Aug. 2007
Association of Nrf2 expression and mutation with Weiss and Helsinki scores in adrenocortical carcinoma., Kamai Takao;Murakami Satoshi;Arai Kyoko;Ishida Kazuyuki;Kijima Toshiki, Cancer science, 113(7), 2368-2377, 25 Apr. 2022
Cancer immunohistogram representing cancer-immunity cycle by immunohistochemistry predicts the efficacy of immune checkpoint inhibitors in urological cancer patients., Kijima Toshiki;Kubo Terufumi;Nishihara Daisaku;Nukui Akinori;Hirohashi Yoshihiko;Torigoe Toshihiko;Kamai Takao, Scientific reports, 12(1), 10617, 23 Jun. 2022
Plasma progastrin-releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis-targeted agents in patients with metastatic castration-resistant prostate cancer., Yashi Masahiro;Nishihara Daisaku;Yokoyama Megumi;Fuchizawa Hirotaka;Okazaki Akihito;Takei Kohei;Suzuki Issei;Sakamoto Kazumasa;Kijima Toshiki;Kobayashi Minoru;Kamai Takao, Cancer reports (Hoboken, N.J.), e1762, 05 Dec. 2022
Circulating tumor cells and cell-free tumor DNA analyses in urothelial cancer using the LiquidBiopsy platform., Kobayashi Minoru;Abe Hideyuki;Arai Kyoko;Murakami Satoshi;Kamai Takao, Current urology, 16(2), 99-106, Jun. 2022
Increased expression of Nrf2 and elevated glucose uptake in pheochromocytoma and paraganglioma with SDHB gene mutation., Kamai Takao;Murakami Satoshi;Arai Kyoko;Nishihara Daisaku;Uematsu Toshitaka;Ishida Kazuyuki;Kijima Toshiki, BMC cancer, 22(1), 289, 18 Mar. 2022
Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma., Nishihara Daisaku;Kijima Toshiki;Arai Kyoko;Kamai Takao, International urology and nephrology, 55(4), 867-874, 04 Jan. 2023
Prostate-specific antigen kinetics contributes to decision making for biopsy referral: the predictive implication for PSA retest in patients with elevated PSA levels., Kobayashi Minoru;Kijima Toshiki;Yashi Masahiro;Kamai Takao, Prostate international, 11(1), 27-33, 24 Aug. 2022
Transperitoneal laparoscopic umbilical resection of urachal remnants: a feasible surgical method., Yuki Hideo;Ohkubo Naoya;Kurashina Ryo;Sakamoto Kazumasa;Suzuki Issei;Takei Kohei;Betsunoh Hironori;Nukui Akinori;Yashi Masahiro;Kamai Takao, BMC urology, 23(1), 57, 04 Apr. 2023
Geriatric 8 and Vulnerable Elders Survey-13 predict length of hospital stay and postoperative complications in Japanese patients undergoing urological surgery., Tokura Yuumi;Kawai Taketo;Takei Kazuki;Ujiie Takashi;Kanatani Atsushi;Yamada Yukio;Kaneko Tomoyuki;Kamai Takao;Nakagawa Tohru, Journal of geriatric oncology, 14(6), 101558, 14 Jun. 2023
36(10), 1153-1157, Oct. 2023
113(7), 2368-2377, Jul. 2022
Natural history and management of ultrasound-detected small renal angiomyolipoma, Kobayashi M, Yokoyama M, Yuki H, Kamai T, J Med Ultrasound, 32(2), 154-160, Jan. 2024
Other
10(1), 11-15, 2019
109(Suppl), S93-S97, Nov. 2018
MRI diagnosis of prostate cancer, Kaji Y, Inamura K, Kamai T, Mebio, 35(2), 18-25, Feb. 2018
72(1), 34-40, Jan. 2018
Case of hydrocele testis caused by vaginalitis, a rare manifestation of immunoglobulin G4-related disease, Tokura Y, Kobayashi MKusakabe TKamai T, Int J Urol, 24(10), 771-773, Oct. 2017
62(1), 8-12, Sep. 2017
75(増刊6 新腎・泌尿器癌(上)), 193-197, Aug. 2017
Diagnostic Impact of 3D-CT with Retrograde Pyelography for Ureteropelvic Junction Obstruction : A Case Report, Takei K, Abe HNishihara DMizuno TTokura YSuzuki ISakamoto KYuki HKambara TBetsunou HYashi MFukabori YKamai TInamura KShioyama YKaji Y, Hinyokika Kiyo, 63(7), 267-270, Jul. 2017
63(7), 267-270, Jul. 2017
4(5), 481-488, Nov. 2016
16(1), 80-83, Feb. 2016
31, 1-5, Feb. 2016
47(13), 1182-1184, Dec. 2015
A Rare Complication of Chylous Leakage After Open Partial Nephrectomy Successfully Resolved by Somatostatin Analogue., Kobayashi M, Kambara T, Kamai T., Urol Case Rep, 3(6), 195-197, Sep. 2015
Six-year follow up of silodosin monotherapy for the treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: What are the factors for continuation or withdrawal?, Yamanishi T, Kaga KFuse MShibata CKamai TUchiyama T, Int J Urol, 22(12), 1143-1148, Aug. 2015
28(7), 1151-1156, Jul. 2015
60(3), 412-419, Mar. 2015
39(3), 347-352, Mar. 2015
39(3), 347-352, Mar. 2015
60(3), 412-419, Mar. 2015
28(1), 57-58, Jan. 2015
Recent advances in the treatment of metastatic renal cell carcinoma, Abe H, Kamai T, Int J Urol, 20(10), 944-955, Oct. 2013
33(11), 188-198, Sep. 2013
26(8), 1299-1302, Aug. 2013
67(8), 563-575, Jul. 2013
22(1), 17-21, Jun. 2013
26(2), 113-124, Feb. 2013
67(1), 27-33, Jan. 2013
9, 1-6, 2013
Renal metanephric adenoma mimicking papillary renal cell carcinoma on computed tomography: a case report, Masuda A, Kamai TMizuno TKambara TAbe HTomita SFukabori YYamanishi TKaji YYoshida K, Urol Int, 90(3), 369-372, Oct. 2012
72(増刊), 518-525, May 2012
72, 518-525, May 2012
25(4), 693-698, Apr. 2012
25(2), 183-192, Feb. 2012
増刊号(2011冬季増刊), 325-334, Nov. 2011
31(12), 1102-1103, Sep. 2011
31(8), 752-753, Jun. 2011
37, 33-37, Mar. 2011
Use of the Airway Scope for awake intubation in five cases, Taguchi A, Arai T, Enomoto Y, Chiba A, Kamishima K, Kuno Y, Okuda Y, Masui, 59(2), 268-272, Feb. 2010
A case of eosinophilic cystitis that was treated with oral suplatast tosilate (IPD-1151T), Watanabe M, Yamaguchi KYamanishi TKamai TYoshida K, Hinyokika Kiyo, 55(11), 715-719, Nov. 2009
A case of iatrogenic ureterovaginal fistula associated with stress urinary incontinence, Watanabe M, Yamanishi TKamai THuruya NHukuda TYoshida K, Hinyokika Kiyo, 55(11), 721-724, Nov. 2009
55(11), 721-724, Nov. 2009
55(11), 715-719, Nov. 2009
29(10), 2450-2455, Oct. 2009
Management of benign prostatic hyperplasia with silodosin, Yamanishi T, Mizuno TKamai TYoshida KSakakibara RUchiyama T, Open Access J Urol, 1, 1-7, Aug. 2009
Interferon alpha and half-dose sorafenib is an effective treatment modality for interferon alpha-resistant metastatic renal cell carcinoma: a case report, Furuya N, Kamai TTokui NAbe HFukabori YYoshida K, Hinyokika Kiyo, 55(6), 323-326, Jun. 2009
55(6), 323-326, Jun. 2009
66(6), 1020-1024, Jun. 2009
27(6), 76-85, Jun. 2009
22(臨増), 326-327, Mar. 2009
Neuromodulation for the treatment of urinary incontinence, Yamanishi T, Kamai TYoshida K, Int J Urol, 15(8), 665-672, Aug. 2008
61, 1049-1055, Dec. 2007
A case report: testicular pure seminoma metastasized to costal bone after 2 years post-operatively, Watanabe M, Kamai TMasuda AHuruya NYonezawa TNiakanishi KKambara TTsujii TYoshida K, Hinyokika Kiyo, 50(7), 505-509, Jul. 2004
Adenocarcinoma with extensive neuroendocrine differentiation arising in an ileal diverticulum: report of a case, Tsujii T, Kambara T, Shimizu K, Tsubaki M, Kamai T, Abe H, Umeda H, Honma K, and Yoshida K-I, Surg. Today, 32(5), 439-442, 2002
13(12), 1501-1505, Dec. 2000
FGF7 as a candidate urine biomarker for prostate cancer detection., Fukabori Y, Yamazaki H, Yanagibayashi A, Yashi M, Abe H, Betsunoh H, Masuda A, Yuki H, Arai K, Kamai T, Apr. 2014, Poster presentation, The 29th Annual Congress of the European Association of Urology,, True
FGFR2IIIb as a candidate urine biomarker for prostate cancer detection, Fukabori Y, Yamazaki H, Kambara T, Yanagibayashi A, Arai K, Kamai T, Oct. 2012, Poster presentation, 32nd Congress of the Societe Internationale d'Urologie, True
Gemcitabine besed chemotherapy for cisplatin-unfit patients of advanced urothelial carcinoma, Abe H, Nishihara D, Mizuno T, Furuya N, Yuki H, Masuda A, Kambara T, Nakanishi K, Honda M, Kamai T, Sep. 2012, Poster presentation, The 29th Japan-Korea Urological Congress, True
Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA is associated with metastasis of renal cell carcinoma, Abe H, Tomosugi N, Kamai T, Arai K, Yoshida K-I, Nov. 2009, Poster presentation, Department of Urology, Dokkyo Medical University, True
The presence and the functional role of muscarinic receptor subtypes in human bladder smooth muscle in patients with normal and detrusor overactivity, Yamanishi T, Mizuno T, Abe H, Kamai T, Arai K, Yoshida K-I, Apr. 2006, Oral presentation, Department of Urology, Dokkyo Medical University, True
Interferon alfa receptor expression in human renal cell carcinoma, Abe H, Masuda A, Kamai T, Yanai Y, Yamauchi H, Ikeda M, Arai K, Kurimoto M, Yoshida K-I, Oct. 2004, Oral presentation, Department of Urology, Dokkyo Medical University, True